Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial episode artwork

EPISODE · Nov 17, 2023 · 8 MIN

Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial

from Dr Alo Show · host Cardiologist & Personal Trainer Dr. Alo

Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics. https://dralo.net/links 

NOW PLAYING

Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial

0:00 8:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Dr Alo Show?

This episode is 8 minutes long.

When was this Dr Alo Show episode published?

This episode was published on November 17, 2023.

What is this episode about?

Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics. https://dralo.net/links 

Can I download this Dr Alo Show episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!